Skip to main content
. 2021 Jul 20;70(4):553–562. doi: 10.1538/expanim.21-0056

Fig. 1.

Fig. 1.

Effect of AP39 on obesity. High-fat-diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) rats were intravenously injected with 0.05 or 0.1 mg/kg AP39 once a day for 7 weeks. (A) Schematic abstract of the experimental process. (B, C) Body weight and food intake of young rats was recorded once a week for 7 weeks. **P<0.01 vs. Control; ^P<0.05, ^^P<0.01 vs. HFD.